Longlong Wang

753 total citations
23 papers, 526 citations indexed

About

Longlong Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Longlong Wang has authored 23 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Longlong Wang's work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Longlong Wang is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Longlong Wang collaborates with scholars based in China, United States and Hong Kong. Longlong Wang's co-authors include Yi Shi, Rong Xiang, Yongjun Piao, Wei Zhou, Yunshan Zhang, Wanxue Xu, Xiaoshuang Wang, Jin Zhao, Gengyi Zou and Xiyang Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Oncogene.

In The Last Decade

Longlong Wang

21 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Longlong Wang China 12 346 172 87 61 59 23 526
Muhammad Tufail China 14 315 0.9× 174 1.0× 125 1.4× 74 1.2× 56 0.9× 57 608
Xuelian Ren China 11 539 1.6× 252 1.5× 116 1.3× 66 1.1× 61 1.0× 37 790
Qiuzhen Liu China 12 348 1.0× 225 1.3× 100 1.1× 46 0.8× 70 1.2× 18 566
Jianwen Zhang China 16 382 1.1× 227 1.3× 140 1.6× 69 1.1× 46 0.8× 27 641
Yonggang Wang China 14 389 1.1× 288 1.7× 122 1.4× 53 0.9× 60 1.0× 30 660
Min Xue China 14 481 1.4× 396 2.3× 93 1.1× 64 1.0× 65 1.1× 28 700
Siwei Li China 13 403 1.2× 129 0.8× 90 1.0× 35 0.6× 40 0.7× 25 556
Wenping Zhou China 12 310 0.9× 99 0.6× 66 0.8× 28 0.5× 48 0.8× 18 468

Countries citing papers authored by Longlong Wang

Since Specialization
Citations

This map shows the geographic impact of Longlong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longlong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longlong Wang more than expected).

Fields of papers citing papers by Longlong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longlong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longlong Wang. The network helps show where Longlong Wang may publish in the future.

Co-authorship network of co-authors of Longlong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Longlong Wang. A scholar is included among the top collaborators of Longlong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longlong Wang. Longlong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Longlong, et al.. (2025). Semaglutide Reprograms Macrophages via the GLP-1R/PPARG/ACSL1 Pathway to Suppress Papillary Thyroid Carcinoma Growth. The Journal of Clinical Endocrinology & Metabolism. 110(10). 2777–2789. 5 indexed citations
3.
Shi, Jie, Rui Zhou, Shuo Wang, et al.. (2024). NEU4-mediated desialylation enhances the activation of the oncogenic receptors for the dissemination of ovarian carcinoma. Oncogene. 43(49). 3556–3569. 5 indexed citations
4.
Li, Tong, Jie Shi, Longlong Wang, et al.. (2023). Thymol targeting interleukin 4 induced 1 expression reshapes the immune microenvironment to sensitize the immunotherapy in lung adenocarcinoma. SHILAP Revista de lepidopterología. 4(5). e355–e355. 11 indexed citations
5.
Wang, Zhenfeng, et al.. (2023). Development and validation of a prognostic nomogram for gallbladder papillary adenocarcinoma. Frontiers in Oncology. 13. 1157057–1157057.
6.
Yan, Jie, Jiayi Wu, Longlong Wang, et al.. (2022). COMMD3-Mediated Endosomal Trafficking of HER2 Inhibits the Progression of Ovarian Carcinoma. Molecular Cancer Research. 21(3). 199–213. 3 indexed citations
7.
Chen, Haojie, Hanqing Wang, Yi Shi, et al.. (2022). Genome-wide CRISPR knockout screening identified G protein pathway suppressor 2 as a novel tumor suppressor for uveal melanoma metastasis. Journal of Cancer Research and Clinical Oncology. 149(7). 3349–3360. 4 indexed citations
8.
Zhao, Jin, Xiaoyu Li, Jie Yan, et al.. (2021). Glucose-sensitive acetylation of Seryl tRNA synthetase regulates lipid synthesis in breast cancer. Signal Transduction and Targeted Therapy. 6(1). 303–303. 20 indexed citations
9.
Li, Jia, Xuan Qin, Jie Shi, et al.. (2021). A systematic CRISPR screen reveals an IL-20/IL20RA-mediated immune crosstalk to prevent the ovarian cancer metastasis. eLife. 10. 17 indexed citations
10.
Wang, Longlong, Lijun Zhou, Jin Zhao, et al.. (2021). Genome-wide CRISPR/Cas9 knockout screening uncovers ZNF319 as a novel tumor suppressor critical for breast cancer metastasis. Biochemical and Biophysical Research Communications. 589. 107–115. 8 indexed citations
11.
Cui, Heyang, Ning Ding, Cheng Chen, et al.. (2021). Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 11. 650891–650891. 9 indexed citations
12.
Qin, Xuan, Shiqing Wang, Yanhua Liu, et al.. (2021). Serotonin/HTR1E signaling blocks chronic stress-promoted progression of ovarian cancer. Theranostics. 11(14). 6950–6965. 30 indexed citations
13.
Chen, Xiaosu, Kejia Xu, Xiaoshuang Wang, et al.. (2021). DCBLD2 Mediates Epithelial-Mesenchymal Transition-Induced Metastasis by Cisplatin in Lung Adenocarcinoma. Cancers. 13(6). 1403–1403. 13 indexed citations
14.
Wang, Xiaoshuang, Xiaoyu Li, Guang‐wei Xu, et al.. (2020). Nucleotide de novo synthesis increases breast cancer stemness and metastasis via cGMP-PKG-MAPK signaling pathway. PLoS Biology. 18(11). e3000872–e3000872. 87 indexed citations
15.
Zou, Gengyi, Xiaotong Zhang, Lun Wang, et al.. (2020). Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription. Theranostics. 10(15). 6839–6853. 105 indexed citations
16.
Li, Yingxi, Xiyang Li, Mei Cao, et al.. (2019). Seryl tRNA synthetase cooperates with POT1 to regulate telomere length and cellular senescence. Signal Transduction and Targeted Therapy. 4(1). 50–50. 23 indexed citations
17.
Wang, Longlong, Ze Liu, Yongjun Piao, et al.. (2019). E6-induced selective translation of WNT4 and JIP2 promotes the progression of cervical cancer via a noncanonical WNT signaling pathway. Signal Transduction and Targeted Therapy. 4(1). 32–32. 19 indexed citations
18.
Xu, Wanxue, Longlong Wang, Wei Zhou, et al.. (2019). Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers. Signal Transduction and Targeted Therapy. 4(1). 55–55. 101 indexed citations
19.
Wang, Zhifeng, et al.. (2019). <p>Long Non-Coding RNA BCAR4 Promotes Growth, Invasion and Tumorigenicity by Targeting miR-2276 to Upregulate MMP7 Expression in Glioma</p>. OncoTargets and Therapy. Volume 12. 10963–10973. 10 indexed citations
20.
Li, Ming, et al.. (2018). H19 induced by oxidative stress confers temozolomide resistance in human glioma cells via activating NF-&kappa;B signaling. OncoTargets and Therapy. Volume 11. 6395–6404. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muhammad Tufail Breakdown of academic impact, for papers by Xuelian Ren Breakdown of academic impact, for papers by Qiuzhen Liu Breakdown of academic impact, for papers by Jianwen Zhang Breakdown of academic impact, for papers by Yonggang Wang Breakdown of academic impact, for papers by Min Xue Breakdown of academic impact, for papers by Siwei Li Breakdown of academic impact, for papers by Wenping Zhou
Rankless by CCL
2026